Personalized Immune Therapy Shown to Extend Survival in Patients with Aggressive Brain Cancer
DCVax®-L Cancer Vaccine Trial at Sarah Cannon Research Institute at HealthONE Shows First Meaningful Survival Extension in Many Years
Stay updated with breaking news from Linkedin Top. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DCVax®-L Cancer Vaccine Trial at Sarah Cannon Research Institute at HealthONE Shows First Meaningful Survival Extension in Many Years
Second consecutive year that HealthONE has been honored.
/PRNewswire/ -- Flip, Indonesia's leading consumer payments platform, today announced a second close of a Series B funding round led by Tencent, with...
Mumbai (Maharashtra) [India] February 16 (ANI/PNN): Yet again, Jio makes a move on Valentine's Day
Yet again, Jio makes a move on Valentine Day. This time Inviting the competition network users to port out and join the Jio family of over 421 million users.